127 related articles for article (PubMed ID: 34325968)
1. The effect of perioperative packed red blood cells transfusion on patient outcomes after liver transplant for hepatocellular carcinoma.
Muaddi H; Abreu P; Ivanics T; Claasen M; Yoon P; Gorgen A; Al-Adra D; Badenoch A; McCluskey S; Ghanekar A; Reichman T; Sapisochin G
HPB (Oxford); 2022 Mar; 24(3):370-378. PubMed ID: 34325968
[TBL] [Abstract][Full Text] [Related]
2. Importance of Intraoperative Transfusions of Packed Red Blood Cells and Fresh Frozen Plasma in Liver Transplantation for Hepatocellular Cancer.
Masior Ł; Grąt M; Grąt K; Krasnodębski M; Wronka KM; Stypułkowski J; Patkowski W; Frączek M; Krawczyk M; Zieniewicz K
Ann Transplant; 2020 Oct; 25():e923665. PubMed ID: 33079923
[TBL] [Abstract][Full Text] [Related]
3. Packed red blood cell donor age affects overall survival in transfused patients undergoing hepatectomy for non-hepatocellular malignancy.
Loftus TJ; Lopez AN; Jenkins TK; Downey EM; Sikora JR; Pelletier JPR; Zendejas IR; Sarosi GA; Thomas RM
Am J Surg; 2019 Jan; 217(1):71-77. PubMed ID: 30172359
[TBL] [Abstract][Full Text] [Related]
4. Perioperative Allogeneic Blood Transfusion Does not Influence Patient Survival After Hepatectomy for Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
Yamashita YI; Hayashi H; Imai K; Okabe H; Nakagawa S; Kitamura F; Uemura N; Nakao Y; Yusa T; Itoyama R; Yamao T; Umesaki N; Miyata T; Chikamoto A; Shimokawa M; Baba H
World J Surg; 2019 Nov; 43(11):2894-2901. PubMed ID: 31312946
[TBL] [Abstract][Full Text] [Related]
5. Transfusions of packed red blood cells in surgery for liver cancer: predictor of impaired overall survival but not recurrence-free survival - impact of blood transfusions in liver surgery.
Giehl-Brown E; Geipel E; Löck S; Dehlke K; Schweipert J; Weitz J; Riediger C
J Gastrointest Surg; 2024 Apr; 28(4):402-411. PubMed ID: 38583890
[TBL] [Abstract][Full Text] [Related]
6. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.
Yang T; Lu JH; Lau WY; Zhang TY; Zhang H; Shen YN; Alshebeeb K; Wu MC; Schwartz M; Shen F
J Hepatol; 2016 Mar; 64(3):583-93. PubMed ID: 26596543
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative autologous transfusion and oncologic outcomes in liver transplantation for hepatocellular carcinoma: a propensity matched analysis.
Sutton TL; Pasko J; Kelly G; Maynard E; Connelly C; Orloff S; Enestvedt CK
HPB (Oxford); 2022 Mar; 24(3):379-385. PubMed ID: 34294524
[TBL] [Abstract][Full Text] [Related]
8. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
9. Blood Cell Salvage and Autotransfusion Does Not Worsen Oncologic Outcomes Following Liver Transplantation with Incidental Hepatocellular Carcinoma: A Propensity Score-Matched Analysis.
Ivanics T; Shubert CR; Muaddi H; Claasen MPAW; Yoon P; Hansen BE; McCluskey SA; Sapisochin G
Ann Surg Oncol; 2021 Oct; 28(11):6816-6825. PubMed ID: 33778907
[TBL] [Abstract][Full Text] [Related]
10. Post-transplant infection improves outcome of hepatocellular carcinoma patients after orthotopic liver transplantation.
Chao JS; Zhao SL; Ou-Yang SW; Qian YB; Liu AQ; Tang HM; Zhong L; Peng ZH; Xu JM; Sun HC
World J Gastroenterol; 2019 Oct; 25(37):5630-5640. PubMed ID: 31602163
[TBL] [Abstract][Full Text] [Related]
11. Safety of the Use of Blood Salvage and Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma.
Han S; Kim G; Ko JS; Sinn DH; Yang JD; Joh JW; Lee SK; Gwak MS
Ann Surg; 2016 Aug; 264(2):339-43. PubMed ID: 26501715
[TBL] [Abstract][Full Text] [Related]
12. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
[TBL] [Abstract][Full Text] [Related]
13. Impact of intraoperative blood salvage and autologous transfusion during liver transplantation for hepatocellular carcinoma.
Pinto MA; Grezzana-Filho TJM; Chedid AD; Leipnitz I; Prediger JE; Alvares-da-Silva MR; de Araújo A; Zahler S; Lopes BB; Giampaoli ÂZD; Kruel CRP; Chedid MF
Langenbecks Arch Surg; 2021 Feb; 406(1):67-74. PubMed ID: 33025077
[TBL] [Abstract][Full Text] [Related]
14. Decrease in the Risk of Posttransplant Hepatocellular Carcinoma Recurrence After the Conversion to Prestorage Leukoreduction for Transfused Red Blood Cells.
Kwon JH; Han S; Jang JS; Lee KW; Ahn JH; Kim K; Jeon S; Gwak MS; Ko JS; Kim GS; Joh JW; Cho D
Transplantation; 2021 Mar; 105(3):577-585. PubMed ID: 32265418
[TBL] [Abstract][Full Text] [Related]
15. Safety of intra-operative blood salvage during liver transplantation in patients with hepatocellular carcinoma, a propensity score-matched survival analysis.
Nutu OA; Sneiders D; Mirza D; Isaac J; Perera MTPR; Hartog H
Transpl Int; 2021 Dec; 34(12):2887-2894. PubMed ID: 34724271
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
17. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
[TBL] [Abstract][Full Text] [Related]
18. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
[TBL] [Abstract][Full Text] [Related]
19. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
Lee EC; Kim SH; Shim JR; Park SJ
Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
[TBL] [Abstract][Full Text] [Related]
20. No impact of perioperative blood transfusion on prognosis after curative resection for hepatocellular carcinoma: a propensity score matching analysis.
Peng T; Zhao G; Wang L; Wu J; Cui H; Liang Y; Zhou R; Liu Z; Wang Q
Clin Transl Oncol; 2018 Jun; 20(6):719-728. PubMed ID: 29080121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
